ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research artwork

Medicine · American College of Cardiology

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

by American College of Cardiology

The American College of Cardiology offers select interviews and summaries of cardiology's most interesting research areas from ACCEL's renowned library, hosted by ACCEL Editor-in-Chief Alison L. Bailey, MD, FACC, FAACPVR.

Latest episodes

Showing 20 · updated from the feed

What About Aspirin From The Time of Primary PCI?

The PREMIUM trial evaluates whether aspirin can be safely omitted in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coro

Nov 17
8 min

Results of the AFFIRMO Trial

Is atrial fibrillation (AF) management as simple as "ABC," or does it require a broader framework such as "SOS" or "CARE"? Contemporary AF care emphasizes an integrated a

Nov 10
14 min

ACCEL Lite: SINGLE-AF: Anticoagulation For AFib With Intermediate Stroke Risk

The SINGLE-AF study evaluated whether direct oral anticoagulant (DOAC) therapy improves outcomes in patients with atrial fibrillation (AFib) who are at intermediate risk

Nov 3
11 min

Remote Exercise SWEDEHEART: Cross-over Trial on Cardiac Telerehabilitation

Remote Exercise SWEDEHEART was designed to address persistently low participation in traditional cardiac rehabilitation following myocardial infarction. By delivering exe

Oct 27
10 min

TRANQUILITY: IL-6, An Important Mediator of CVD

The TRANQUILITY trial was designed to evaluate whether pacibekitug can reduce interleukin-6 (IL-6)-driven inflammation, a key inflammatory pathway increasingly linked to

Oct 20
17 min

CAC Use in CV Risk Stratification: CorCal Outcomes

The CorCal Outcomes study showed that using coronary artery calcium (CAC) scoring to guide statin therapy for the primary prevention of atherosclerotic cardiovascular dis

Oct 13
12 min

Aficamten For Symptomatic Nonobstructive HCM: ACACIA-HCM Trial

Among patients with symptomatic nonobstructive hypertrophic cardiomyopathy (HCM), treatment with aficamten resulted in significantly greater improvements in exercise capa

Oct 6
12 min

PRESC1SE-MI: Efficacy of the ESC 0/1-hour Pathway

The PRESC1SE-MI trial evaluated whether an accelerated diagnostic pathway for suspected myocardial infarction could improve Emergency Department efficiency without compro

Sep 29
12 min

Antithrombotic Therapy After TAVI

As TAVI expands to younger and healthier patients, valve durability has become an increasingly important consideration. However, the optimal antithrombotic strategy to su

Sep 22
13 min

Insights From the PVI-SHAM-AF

Catheter ablation is frequently performed to improve quality of life in patients with atrial fibrillation (AF). This randomized multicenter trial compared catheter ablati

Sep 15
13 min

Impacts Of The FUND-HF Trial

The FUND-HF trial found that financial support provided soon after hospitalization is a practical strategy for improving medication adherence among economically vulnerabl

Sep 8
10 min

Primordial Prevention of CVD in Young

The future of cardiovascular health depends on prevention that begins early in life. This episode reviews strategies for recognizing cardiovascular risk at an early stage

Sep 1
11 min

Umbrella: Cardioprotection During Treatment

Cardiovascular protection during cancer treatment is critical to help prevent complications such as heart failure. Patients should be educated on risk factors, symptom aw

Aug 25
11 min

No Murmur But Much Fervor: Nonobstructive HCM

Nonobstructive hypertrophic cardiomyopathy (HCM) represents one of the greatest areas of unmet need in HCM management. A key question is identifying the primary driver of

Aug 18
12 min

Evolocumab In Patients Without Significant Atherosclerosis: Results From VESALIUS-CV

The VESALIUS-CV trial demonstrated that the PCSK9 inhibitor evolocumab significantly reduced the risk of a first major cardiovascular event in patients with diabetes who

Aug 11
9 min

Why Can't We Prove Revascularization Is Better Than Medical Therapy for SIHD?

Randomized trials in stable ischemic heart disease (SIHD) show revascularization does not reduce death or myocardial infarction versus guideline-directed medical therapy,

Aug 4
10 min

Top Practice-Changing Advancements in Echocardiography Since ACC.25

ecent advancements in echocardiography since ACC.25 highlight a shift toward greater precision, efficiency, and consistency in cardiac imaging. Standardized echo reportin

Jul 28
10 min

The Case For Medically Tailored Meals

The "Food is Medicine" approach is central to cardiovascular disease (CVD) prevention because diet directly shapes key risk factors, making nutrition a powerful, modifiab

Jul 21
11 min

Managing Subclinical AFib Detected by Devices, Ambulatory Monitors and Wearables

The detection of subclinical, or "silent," atrial fibrillation (AFib) has increased substantially with the widespread use of implantable devices (e.g., pacemakers, defibr

Jul 14
9 min

Cardiorenal Outcomes with Tirzepatide Compared with Dulaglutide in Patients with Diabetes and CVD

Is tirzepatide associated with a broader reduction in cardiorenal adverse outcomes compared with dulaglutide in patients with type 2 diabetes and cardiovascular disease (

Jul 7
10 min

Chart trend

Position in the Medicine chart (US), last 90 days.

#98
all-time peak
1
day in the top 100 since Dec 2024

Chart positions

Where ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research ranks today in each Apple Podcasts chart (US, Nov 22, 2026).

#164 ▼ 37 Medicine US

What listeners say

A curated, balanced selection of Apple Podcasts reviews.

I really like this podcast. I disagree with many reviewers that it’s short. It’s the perfect length for listening on a walk or a commute or a break. If you want an hour-long plus podcast then you should be checking out the website or journal.

Ramster1 · Jan 2026

Lot of negative reviews for how short and superficial the episodes are. I disagree - I think this short form is really helpful, and while nobody would argue it doesn’t allow for depth, it’s a great springboard to go deeper if you want (you can always read the journal article or ACC’s summary online if you want more.) Sometimes I just have 10 minutes, and this fits the bill perfectly. Keep it up!!

dashuaige · Mar 2024

I would call this UltraLite. Even 30 - 45 minutes per episode of interviews similar to what ACCEL used to provide would be much more helpful to the busy clinician. We need to hear a 10 - 12 min conversation with those individuals who are heading or participating on the committees writing the new or updated clinical practice guidelines or involved it cutting-edge, clinically-relevant research interviewed by another individual who can ask important and revealing questions. That is all we need. Eliminate the fluff. Time is important. These episodes need to be succinct and enlightening with the goal to keep the busy clinician current and able to integrate this kind of info into practice.

FCFUNK · Oct 2022

Occasionally, the interviewers and their subjects provide important new information or well thought out summaries of new guidelines. More often than not however this feels like a talk show, with some nice discussion and nothing new that I will implement in my practice. Some of the interviewers in particular are extremely flowery and complementary, bordering on obsequious and nauseating.

JMW-WW1 · Apr 2024

I love this podcast, but I miss the breadth and depth of interviews that I used to hear on the original ACCEL/Audio Digest. I felt I could keep up with new developments and thinking by listening to the 3 hours of interviews each month, but now ACCEL is much more limited, thus “Lite.”

RandalHu · Apr 2025

We strive to present a balanced view by showing a diverse range of reviews from Apple Podcasts.

More podcasts like ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Popular shows in Medicine, for your next listen.

Browse charts by category

Daily updated Apple Podcasts rankings for the United States.

About ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research on Reason.fm

Here you find the Apple Podcasts chart positions of ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research, its latest episodes to listen to directly, and reviews from listeners. Rankings are updated daily for the United States.

Contact

Questions or issues? Reach us at hello@reason.fm

0:000:00